ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · Real-Time Price · USD
0.700
+0.115 (19.59%)
At close: Feb 21, 2025, 4:00 PM
0.690
-0.010 (-1.37%)
After-hours: Feb 21, 2025, 7:00 PM EST
ABVC BioPharma Market Cap
ABVC BioPharma has a market cap or net worth of $8.57 million as of February 21, 2025. Its market cap has decreased by -15.19% in one year.
Market Cap
8.57M
Enterprise Value
11.10M
1-Year Change
-15.19%
Ranking
Category
Stock Price
$0.70
Market Cap Chart
Since August 3, 2021, ABVC BioPharma's market cap has decreased from $79.50M to $8.57M, a decrease of -89.22%. That is a compound annual growth rate of -46.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 9.10M | 18.18% |
| Dec 31, 2024 | 7.70M | -8.33% |
| Dec 29, 2023 | 8.40M | -58.82% |
| Dec 30, 2022 | 20.40M | -78.97% |
| Dec 31, 2021 | 97.00M | 22.01% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 780.72B |
| UnitedHealth Group | 470.30B |
| Johnson & Johnson | 380.14B |
| Novo Nordisk | 370.06B |
| AbbVie | 348.39B |
| Abbott Laboratories | 229.17B |
| AstraZeneca | 228.16B |
| Intuitive Surgical | 217.02B |